Clinical Trials

30 enrolled

BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

NCT02379429 2026-02-17

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue

500 enrolled

Urinary Bladder Neoplasms, Urologic Neoplasms

NCT04731376 2026-02-11

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

56 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Hypogonadism, Urologic Diseases, Urologic Neoplasms

NCT06238479 2026-02-11

EXCEED

Phase 1 Recruiting

490 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Ureteral Neoplasms, Urologic Neoplasms, Triple Negative Breast Neoplasms

NCT03091192 2026-01-23

Savolitinib vs. Sunitinib in MET-driven PRCC.

Phase 3 Active not recruiting

60 enrolled 15 charts

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Carcinoma, Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms by Site, Urologic Neoplasms

NCT06465069 2026-01-22

NEXUS-01

Phase 1 Recruiting

420 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Ureteral Neoplasms, Urologic Neoplasms, Triple Negative Breast Neoplasms

NCT05544552 2026-01-12

SURF301

Phase 1/2 Active not recruiting

310 enrolled

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis, Urologic Neoplasms

NCT06111235 2026-01-12

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

367 enrolled

Phase 2 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Neoplasms

NCT03541902 2026-01-09

Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma

32 enrolled

Carcinoma, Renal Cell, Urologic Neoplasms

NCT06680089 2025-12-31

CD70-targeted immunoPET Imaging of Kidney Cancer

Phase 2 Recruiting

300 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasms, Urogenital Neoplasms, Urologic Neoplasms

NCT07305142 2025-12-26

Comparison of the Integrated Posterior-Anterior-Lateral Approach and the Posterior Approach in Robotic Radical Prostatectomy

Phase NA Completed

60 enrolled

Urologic Neoplasms

NCT02276924 2025-12-24

UROVISIO

Phase NA Completed

29 enrolled

Multicystic renal dysplasia, bilateral, Hematuria, Urologic Neoplasms, Nephrolithiasis

NCT06353906 2025-12-08

PRIAM

Phase 2 Recruiting

27 enrolled

Penile Neoplasms, Urogenital Neoplasms, Urologic Neoplasms, Male Urogenital Diseases

NCT06676527 2025-12-05

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

39 enrolled

Phase NA Not yet recruiting

Urogenital Diseases, Carcinoma, Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Female Urogenital Diseases, Male Urogenital Diseases

NCT07252882 2025-11-28

UUTICaD

178 enrolled

Urologic Neoplasms

NCT06545188 2025-11-24

MOST-D

Phase NA Completed

746 enrolled

DermatologicGenitourinarySarcoma

Necrophobia, Urologic Neoplasms

NCT03093909 2025-11-10

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Phase 1 Recruiting

44 enrolled

Bone Neoplasms, Melanoma, Osteosarcoma, Urologic Neoplasms

NCT03288545 2025-11-10

EV-103

Phase 1/2 Active not recruiting

348 enrolled 1 FDA

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms, Urologic Neoplasms

NCT05169437 2025-10-29

PAVO

Phase 2 Terminated

22 enrolled 17 charts

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Urologic Neoplasms, Endometrial Neoplasms

NCT05241340 2025-10-24

RAD-VACCINE

Phase 2 Active not recruiting

33 enrolled

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT01552434 2025-10-14

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

155 enrolled

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

NCT03435952 2025-10-14

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

18 enrolled

BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

NCT05785039 2025-09-26

A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System Tumors

Phase 2 Recruiting

76 enrolled

Urologic Neoplasms

NCT04442724 2025-08-14

FMBRT

60 enrolled

Classical hematologyGenitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Urologic Neoplasms

NCT05920343 2025-07-10

PREVENT-GU

Phase 2/3 Recruiting

120 enrolled

Urogenital Neoplasms, Urologic Neoplasms, Venous Thromboembolism

NCT05887245 2025-06-27

Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy

Active not recruiting

200 enrolled

DermatologicGenitourinary

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Urogenital Neoplasms, Urologic Neoplasms

NCT02836795 2025-06-08

Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors

Phase 1 Completed

35 enrolled

Melanoma, Urologic Neoplasms

NCT06398314 2025-05-23

PALLSOFT

GastrointestinalGenitourinary

200 enrolled

Gastrointestinal Neoplasms, Urologic Neoplasms

NCT05725304 2025-05-22

The Registry of Genetic Expression of Taiwan Urologic Cancer

Active not recruiting

500 enrolled

Urologic Neoplasms

NCT05874921 2025-02-28

uTRACT

400 enrolled

Phase EARLY_PHASE1 Completed

Carcinoma, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Recurrence, Urogenital Neoplasms, Urologic Neoplasms

NCT03473730 2025-01-30

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

17 enrolled

Carcinoma, Renal Cell, Urologic Neoplasms

NCT06452212 2024-11-21

Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients

Completed

23 enrolled

Urologic Neoplasms

NCT04005183 2024-10-10

REMEDY

Completed

146 enrolled

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT03219333 2024-08-27

EV-201

219 enrolled 32 charts 2 FDA

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms, Urologic Neoplasms

NCT06537037 2024-08-05

Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach（Radiogenomics-Urinary）

150 enrolled

Phase 2 Not yet recruiting

Urologic Neoplasms

NCT06427057 2024-05-23

A Study of Cadonilimab（AK104）Combined With Standard Treatment for Function Preservation in Urinary System Tumors

40 enrolled

EndocrineGenitourinaryNET

Urologic Neoplasms

NCT01398306 2024-05-06

BANN

Completed

40 enrolled

Adenocarcinoma, Carcinoid Tumor, Carcinoma, Carcinoma, Renal Cell, Adenoma, Islet Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Urogenital Neoplasms, Urologic Neoplasms, Neuroendocrine Tumors

NCT06397287 2024-05-02

PROM Project Urology

47 enrolled

Urologic Diseases, Urologic Neoplasms

NCT06357416 2024-05-01

MV

4,000 enrolled

700 enrolled 35 charts 2 FDA

Alcoholism, Urinary Bladder Neoplasms, Diabetes Mellitus, Hypertension, Kidney Neoplasms, Prostatic Neoplasms, Smoking, Testicular Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT02603432 2024-03-27

JAVELIN Bladder 100

Phase 3 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Neoplasms

NCT03339843 2024-03-15

MiMe-A

GastrointestinalGenitourinaryGynecologic

85 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Neoplasms, Urologic Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT04544748 2024-03-06

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

DermatologicGenitourinaryThoracic

48 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urologic Neoplasms

NCT00019396 2024-03-04

flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Neoplasms, Skin Neoplasms, Urologic Neoplasms

NCT00019539 2024-03-04

Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer